We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
China Medicine Corporation (CE) | USOTC:CHME | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
(Check One):
|
Form 10-K
Form 20-F
Form 11-K
S
Form 10-Q
Form N-SAR
Form N-CSR
|
For Period Ended:
September 30, 2011
|
|
Transition Report on Form 10-K
|
|
Transition Report on Form 20-F
|
|
Transition Report on Form 11-K
|
|
Transition Report on Form 10-Q
|
|
Transition Report on Form N-SAR
|
|
For the Transition Period Ended: ________________________
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
||||
o
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|||
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
(1)
|
Name and telephone number of person to contact in regard to this notification
|
Senshan Yang, Chief Executive Officer
|
8620
|
8739-1718
|
|||
(Name)
|
(Area Code)
|
(Telephone Number)
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
|
Yes
T
No
|
|
Annual Report on Form 10-K for the fiscal year ended December 31, 2010; Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2011; Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011.
|
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
T
Yes
No
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
|
The Company is currently conducting an internal review to determine the degree of material inaccuracy of the previously issued financial statements and the underlying causes. The Company is currently unable to quantify the extent of the required accounting adjustments pending completion of its internal review. As a result, the Company is unable to estimate the anticipated change in its results of operations for the quarter ended September 30, 2011, as compared to the quarter ended September 30, 2010, as of the date of this notification.
|
Date: November 15, 2011
|
By:
|
/s/ Senshan Yang
|
|
Name: Senshan Yang
|
|||
Title: Chief Executive Officer
|
1 Year China Medicine (CE) Chart |
1 Month China Medicine (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions